Evidence map›Paper›PMID 37087452›Full record

SynthesisBMC cardiovascular disorders2023

The global prevalence of myocardial infarction: a systematic review and meta-analysis.

Nader Salari, Fatemeh Morddarvanjoghi, Amir Abdolmaleki, Shabnam Rasoulpoor, Ali Asghar Khaleghi, Leila Afshar Hezarkhani, Shamarina Shohaimi, Masoud Mohammadi

2 registry-linked trialsOpen access · goldAbstract readMeta-AnalysisSystematic Review
In one paragraph

Synthesis in BMC cardiovascular disorders, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 307 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
307citing papers in PubMed, 4 pooled it
104.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06871358 nacompletednot on this mapstarted 2024, after this paper: background citation

The Effect of Pre- and Post-Administration of 80 mg Atorvastatin on Hs-CRP/Albumin Ratio in Reducing Thrombus Burden in STEMI Patients Undergoing Primary PCI

TypeinterventionalSponsorUniversitas Sebelas MaretRan2024 to 2024Enrolled40ConditionsSTEMI (STE-ACS), Primary PCI for STEMIArmsAtorvastatin 80mg, Placebo
NCT06882044 nacompletednot on this map

The Effect of a Mobile Application on Treatment Adherence, Self-Management, and Quality of Life in Patients With Acute Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention

TypeinterventionalSponsorTrakya UniversityRan2021 to 2024Enrolled61ConditionsAcute Myocardial Infarction (AMI), Mobile Health Technology (mHealth), Quality of Lifte, Treatment AdherenceArmsmHealth
3 · Its place in the literature

Who cites it

307 citing papers in PubMed, 4 syntheses or guidelines pooled it, 466 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Review
  7. Article
  8. Article
  9. Effects of Intensive Early Physiotherapy Intervention After Myocardial Infarction on Quality of Life, Anxiety and Depression Scores: A Controlled Clinical Trial.Physiotherapy research international : the journal for researchers and clinicians in physical therapy · 2026
    Article
  10. Article
  11. Cardioprotective Effects ofLife (Basel, Switzerland) · 2026
    Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Observational

247 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 2 countries.

Nader SalariDepartment of Biostatistics, School of Health, Kermanshah University of Medical Sciences, Kermanshah, Iran.
Fatemeh MorddarvanjoghiStudent Research Committee, Kermanshah University of Medical Sciences, Kermanshah, Iran.
Amir AbdolmalekiDepartment of Operating Room, Nahavand School of Allied Medical Sciences, Hamadan University of Medical Sciences, Hamadan, Iran.
Shabnam RasoulpoorDepartment of Psychiatric Nursing, Miandoab School of Nursing, Urmia University of Medical Sciences, Urmia, Iran.
Ali Asghar KhaleghiCellular and Molecular Research Center, Gerash University of Medical Sciences, Gerash, Iran.
Leila Afshar HezarkhaniNeuroscience Research Center, Health Technology Institute, Kermanshah University of Medical Sciences, Kermanshah, Iran.
Shamarina ShohaimiDepartment of Biology, Faculty of Science, University Putra Malaysia, Serdang, Selangor, Malaysia.
Masoud MohammadiCellular and Molecular Research Center, Gerash University of Medical Sciences, Gerash, Iran. Masoud.mohammadi1989@yahoo.com.
Kermanshah University of Medical Sciences · IRGerash University of Medical Sciences · IRHamedan University of Medical Sciences · IRUniversiti Putra Malaysia · MYUrmia University · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMyocardial infarction (MI) is one of the life-threatening coronary-associated pathologies characterized by sudden cardiac death. The provision of complete insight into MI complications along with designing a preventive program against MI seems necessary.

methodsVarious databases (PubMed, Web of Science, ScienceDirect, Scopus, Embase, and Google scholar search engine) were hired for comprehensive searching. The keywords of "Prevalence", "Outbreak", "Burden", "Myocardial Infarction", "Myocardial Infarct", and "Heart Attack" were hired with no time/language restrictions. Collected data were imported into the information management software (EndNote v.8x). Also, citations of all relevant articles were screened manually. The search was updated on 2022.9.13 prior to the publication.

resultsTwenty-two eligible studies with a sample size of 2,982,6717 individuals (< 60 years) were included for data analysis. The global prevalence of MI in individuals < 60 years was found 3.8%. Also, following the assessment of 20 eligible investigations with a sample size of 5,071,185 individuals (> 60 years), this value was detected at 9.5%.

conclusionDue to the accelerated rate of MI prevalence in older ages, precise attention by patients regarding the complications of MI seems critical. Thus, determination of preventive planning along with the application of safe treatment methods is critical.

Indexed as

Myocardial InfarctionHumansHeart attackMIMyocardial infarctionPrevalence

Identifiers

PMID37087452
PMCPMC10122825
OpenAlexW4366769366

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.